Montelukast Prescribing at CASTLE PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,059
Total Quantity
65.9K
NHS Cost
£3.9K
vs National Avg
+200.7%
CASTLE PARTNERSHIP prescribed 2,059 items of Montelukast over the last 12 months at a cost of £3,938 to the NHS. This is 200.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
184
Jun 2026
167
Jun 2026
180
Jun 2026
162
Jun 2026
166
Jun 2026
179
Jun 2026
175
Jun 2026
171
Jun 2026
175
Jun 2026
162
Jun 2026
165
Jun 2026
173
Prescribing Details
| Total Items | 2,059 |
|---|---|
| Total Quantity | 65,917 |
| Total NHS Cost | £3,938 |
| Presentations | 5 different forms |
| vs National Average | +200.7% |
Montelukast Prescribing Comparison
| This practice | 2,059 items |
|---|---|
| National average per practice | 685 items |
| Difference | +200.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.